Skip to main content

Published locations for Novel RA strategy: Target first-line biologics for likely methotrexate nonresponders

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Novel RA strategy: Target first-line biologics for likely methotrexate nonresponders

User login

  • Reset your password
  • /content/novel-ra-strategy-target-first-line-biologics-likely-methotrexate-nonresponders
  • /clinicianreviews/article/195909/rheumatoid-arthritis/novel-ra-strategy-target-first-line-biologics
  • /internalmedicinenews/article/195909/rheumatoid-arthritis/novel-ra-strategy-target-first-line
  • /rheumatologynews/article/195909/rheumatoid-arthritis/novel-ra-strategy-target-first-line-biologics
  • /jcomjournal/article/195909/rheumatoid-arthritis/novel-ra-strategy-target-first-line-biologics-likely
  • /rheumatology/article/195909/rheumatoid-arthritis/novel-ra-strategy-target-first-line-biologics
  • /internalmedicine/article/195909/rheumatoid-arthritis/novel-ra-strategy-target-first-line-biologics